clarithromycin has been researched along with ribavirin in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (58.33) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chan, PK; Cheng, WT; Chiu, MC; Chu, WC; Fok, TF; Fong, NC; Hon, KL; Kwan, YW; Leung, CW; Li, AM; Li, CK; Ng, PC; Tam, JS | 1 |
Allen, U; Babyn, P; Bitnun, A; Ford-Jones, EL; Heurter, H; King, SM; Kitai, I; Manson, D; Matlow, A; Opavsky, MA; Read, S; Richardson, S; Tellier, R | 1 |
Chang, SG; Chao, CL; Chen, YM; Chien, LC; Chou, P; Ho, MS; Hsu, CH; Hwang, KC; Ker, CC; Lin, JG | 1 |
1 review(s) available for clarithromycin and ribavirin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for clarithromycin and ribavirin
Article | Year |
---|---|
The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients.
Topics: Adolescent; Adult; Antiviral Agents; Clarithromycin; Combined Modality Therapy; Drugs, Chinese Herbal; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Lung; Male; Methylprednisolone; Middle Aged; Radiography; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Taiwan | 2006 |
10 other study(ies) available for clarithromycin and ribavirin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Clinical presentations and outcome of severe acute respiratory syndrome in children.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Cefotaxime; Child; Child, Preschool; Clarithromycin; Disease Outbreaks; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Hong Kong; Humans; Infant; Injections, Intravenous; Lung; Lymphopenia; Methylprednisolone; Oxygen Inhalation Therapy; Prednisolone; Prospective Studies; Ribavirin; Severe Acute Respiratory Syndrome; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Children hospitalized with severe acute respiratory syndrome-related illness in Toronto.
Topics: Adolescent; Antiviral Agents; Asia; Child; Child, Hospitalized; Child, Preschool; Clarithromycin; Cohort Studies; Disease Outbreaks; Disease Transmission, Infectious; Female; Hospitals, Pediatric; Humans; Infant; Male; Ontario; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Travel | 2003 |